Literature DB >> 26230152

A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function.

Kiel M Telesford1, Wang Yan, Javier Ochoa-Reparaz, Anudeep Pant, Christopher Kircher, Marc A Christy, Sakhina Begum-Haque, Dennis L Kasper, Lloyd H Kasper.   

Abstract

Polysaccharide A (PSA) derived from the human commensal Bacteroides fragilis is a symbiosis factor that stimulates immunologic development within mammalian hosts. PSA rebalances skewed systemic T helper responses and promotes T regulatory cells (Tregs). However, PSA-mediated induction of Foxp3 in humans has not been reported. In mice, PSA-generated Foxp3(+) Tregs dampen Th17 activity thereby facilitating bacterial intestinal colonization while the increased presence and function of these regulatory cells may guard against pathological organ-specific inflammation in hosts. We herein demonstrate that PSA induces expression of Foxp3 along with CD39 among naïve CD4 T cells in vitro while promoting IL-10 secretion. PSA-activated dendritic cells are essential for the mediation of this regulatory response. When cultured with isolated Foxp3(+) Tregs, PSA enriched Foxp3 expression, enhanced the frequency of CD39(+)HLA-DR(+) cells, and increased suppressive function as measured by decreased TNFα expression by LPS-stimulated monocytes. Our findings are the first to demonstrate in vitro induction of human CD4(+)Foxp3(+) T cells and enhanced suppressive function of circulating Foxp3(+) Tregs by a human commensal bacterial symbiotic factor. Use of PSA for the treatment of human autoimmune diseases, in particular multiple sclerosis and inflammatory bowel disease, may represent a new paradigm in the approach to treating autoimmune disease.

Entities:  

Keywords:  B. fragilis, Bacteroides fragilis; Bacteroides fragilis; DC, Dendritic cell; Foxp3; GF, Germ Free; MS, Multiple sclerosis; NCD4, Naïve CD4; PBMCs, Peripheral blood mononuclear cells; PSA, Polysaccharide A; SPF, Specific pathogen free; Sp1, Streptococcus pneumoniae polysaccharide type 1; T regulatory cells; Treg, T regulatory cell; ZPS, Zwitterionic polysaccharide.; autoimmunity; commensal microbiota; dendritic cell; ectonuclease; multiple sclerosis; pDC, Plasmacytoid dendritic cell; zwitterionic polysaccharide

Mesh:

Substances:

Year:  2015        PMID: 26230152      PMCID: PMC4615798          DOI: 10.1080/19490976.2015.1056973

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  50 in total

1.  Interactions between commensal intestinal bacteria and the immune system.

Authors:  Andrew J Macpherson; Nicola L Harris
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

Review 2.  Intestinal commensal microbes as immune modulators.

Authors:  Ivaylo I Ivanov; Kenya Honda
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

Review 3.  Once a Treg, always a Treg?

Authors:  Deepali V Sawant; Dario A A Vignali
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

4.  Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions.

Authors:  Wiltrud M Kalka-Moll; Arthur O Tzianabos; Paula W Bryant; Marcus Niemeyer; Hidde L Ploegh; Dennis L Kasper
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

Review 5.  CD39 and CD73 in immunity and inflammation.

Authors:  Luca Antonioli; Pál Pacher; E Sylvester Vizi; György Haskó
Journal:  Trends Mol Med       Date:  2013-04-17       Impact factor: 11.951

6.  Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms.

Authors:  Suryasarathi Dasgupta; Deniz Erturk-Hasdemir; Javier Ochoa-Reparaz; Hans-Christian Reinecker; Dennis L Kasper
Journal:  Cell Host Microbe       Date:  2014-04-09       Impact factor: 21.023

7.  Polysaccharide processing and presentation by the MHCII pathway.

Authors:  Brian A Cobb; Qun Wang; Arthur O Tzianabos; Dennis L Kasper
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

8.  Fingolimod increases CD39-expressing regulatory T cells in multiple sclerosis patients.

Authors:  Nathalie Muls; Hong Anh Dang; Christian J M Sindic; Vincent van Pesch
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

9.  CD39 and CD161 modulate Th17 responses in Crohn's disease.

Authors:  Aiping Bai; Alan Moss; Efi Kokkotou; Anny Usheva; Xiaofeng Sun; Adam Cheifetz; Yi Zheng; Maria Serena Longhi; Wenda Gao; Yan Wu; Simon C Robson
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

10.  Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.

Authors:  Nicholas Arpaia; Clarissa Campbell; Xiying Fan; Stanislav Dikiy; Joris van der Veeken; Paul deRoos; Hui Liu; Justin R Cross; Klaus Pfeffer; Paul J Coffer; Alexander Y Rudensky
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

View more
  80 in total

1.  Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells.

Authors:  Luisa Cervantes-Barragan; Jiani N Chai; Ma Diarey Tianero; Blanda Di Luccia; Philip P Ahern; Joseph Merriman; Victor S Cortez; Michael G Caparon; Mohamed S Donia; Susan Gilfillan; Marina Cella; Jeffrey I Gordon; Chyi-Song Hsieh; Marco Colonna
Journal:  Science       Date:  2017-08-03       Impact factor: 47.728

2.  Antigen-Specific CD4+ T Cell-Derived Gamma Interferon Is Both Necessary and Sufficient for Clearing Chlamydia from the Small Intestine but Not the Large Intestine.

Authors:  Hui Lin; Conghui He; John J Koprivsek; Jianlin Chen; Zhiguang Zhou; Bernard Arulanandam; Zhenming Xu; Lingli Tang; Guangming Zhong
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

Review 3.  Adapting Cancer Immunotherapy Models for the Real World.

Authors:  Lauryn E Klevorn; Ryan M Teague
Journal:  Trends Immunol       Date:  2016-04-19       Impact factor: 16.687

4.  Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitors.

Authors:  Jibran Ahmed; Arun Kumar; Kaushal Parikh; Asad Anwar; Bettina M Knoll; Carmelo Puccio; Hoo Chun; Michael Fanucchi; Seah H Lim
Journal:  Oncoimmunology       Date:  2018-08-20       Impact factor: 8.110

Review 5.  Respiratory tract mucous membrane microecology and asthma.

Authors:  Xingyuan Chen; Chen Qiu
Journal:  Ann Transl Med       Date:  2019-09

Review 6.  The gut-eye-lacrimal gland-microbiome axis in Sjögren Syndrome.

Authors:  Claudia M Trujillo-Vargas; Laura Schaefer; Jehan Alam; Stephen C Pflugfelder; Robert A Britton; Cintia S de Paiva
Journal:  Ocul Surf       Date:  2019-10-20       Impact factor: 5.033

Review 7.  Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

Authors:  Ethan Craig; Laura C Cappelli
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

8.  Regulation of Autoimmunity by the Microbiome.

Authors:  Carlos R Zárate-Bladés; Reiko Horai; Rachel R Caspi
Journal:  DNA Cell Biol       Date:  2016-07-27       Impact factor: 3.311

Review 9.  Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.

Authors:  Thomas Siegmund Postler; Sankar Ghosh
Journal:  Cell Metab       Date:  2017-06-15       Impact factor: 27.287

10.  Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties.

Authors:  C Preston Neff; Matthew E Rhodes; Kathleen L Arnolds; Colm B Collins; Jody Donnelly; Nichole Nusbacher; Paul Jedlicka; Jennifer M Schneider; Martin D McCarter; Michael Shaffer; Sarkis K Mazmanian; Brent E Palmer; Catherine A Lozupone
Journal:  Cell Host Microbe       Date:  2016-09-29       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.